These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12943492)

  • 1. C-peptide and diabetic neuropathy.
    Sima AA
    Expert Opin Investig Drugs; 2003 Sep; 12(9):1471-88. PubMed ID: 12943492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 diabetic neuropathy and C-peptide.
    Sima AA; Zhang W; Grunberger G
    Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?
    Sima AA; Kamiya H
    Curr Drug Targets; 2008 Jan; 9(1):37-46. PubMed ID: 18220711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological mechanisms involved in diabetic neuropathy: can we slow the process?
    Sima AA
    Curr Opin Investig Drugs; 2006 Apr; 7(4):324-37. PubMed ID: 16625819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration.
    Pierson CR; Zhang W; Sima AA
    J Neuropathol Exp Neurol; 2003 Jul; 62(7):765-79. PubMed ID: 12901702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pleiotropic action of proinsulin C-peptide].
    Usarek M; Bryła J
    Postepy Hig Med Dosw (Online); 2012 Mar; 66():135-45. PubMed ID: 22470188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of diabetic neuropathy: axon dysfunction.
    Sima AA; Zhang W
    Handb Clin Neurol; 2014; 126():429-42. PubMed ID: 25410237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data.
    Sima AA
    CNS Drugs; 2007; 21 Suppl 1():13-23; discussion 45-6. PubMed ID: 17696589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide: new findings and therapeutic possibilities.
    Wahren J; Larsson C
    Diabetes Res Clin Pract; 2015 Mar; 107(3):309-19. PubMed ID: 25648391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the metabolic and molecular basis for diabetic neuropathy.
    Sima AA
    Cell Mol Life Sci; 2003 Nov; 60(11):2445-64. PubMed ID: 14625688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
    Sima AA; Zhang W; Sugimoto K; Henry D; Li Z; Wahren J; Grunberger G
    Diabetologia; 2001 Jul; 44(7):889-97. PubMed ID: 11508275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and nerve fiber regeneration in type 1 diabetic neuropathy.
    Pierson CR; Zhang W; Murakawa Y; Sima AA
    J Neuropathol Exp Neurol; 2003 Mar; 62(3):260-71. PubMed ID: 12638730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial effects of C-Peptide on diabetic polyneuropathy.
    Kamiya H; Zhang W; Sima AA
    Rev Diabet Stud; 2009; 6(3):187-202. PubMed ID: 20039008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects on biological activity of C-peptide in IDDM patients.
    Forst T; Kunt T; Pfützner A; Beyer J; Wahren J
    Exp Clin Endocrinol Diabetes; 1998; 106(4):270-6. PubMed ID: 9792458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes.
    Ekberg K; Johansson BL
    Exp Diabetes Res; 2008; 2008():457912. PubMed ID: 18350117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proinsulin C-peptide -- the bioactive peptide with a huge promise].
    Walenciak Ł; Fendler W; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2007; 13(2):95-8. PubMed ID: 17880815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.
    Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Zhang W; Sima AA
    J Neuropathol Exp Neurol; 2004 May; 63(5):450-60. PubMed ID: 15198124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of C-peptide on microvascular blood flow and blood hemorheology.
    Forst T; Kunt T
    Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.
    Sima AA; Zhang W; Li ZG; Kamiya H
    Exp Diabetes Res; 2008; 2008():230458. PubMed ID: 18437223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.